Silver Book Fact

The U.S. Food and Drug Administration has approved five drugs that temporarily improve Alzheimer’s disease symptoms.

Alzheimer's Association. 2012 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2012; 8(2): 131-68. http://www.alzheimersanddementia.com/article/S1552-5260(12)00032-5/fulltext

Reference

Title
2012 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2012
Authors
Alzheimer's Association
Volume & Issue
Volume 8, Issue 2
Pages
131-68
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Medicaid Costs, 5-Year Delayed Onset  
  • It is imperative to weigh costs of implementing new technologies for predicting onset of Alzheimer’s disease through biomarkers and delaying onset earlier against the potential benefits of improving health. Overall…  
  • According to the Pharmaceutical Research and Manufacturers of America, one of the most promising medicines in development uses normal human cells to enhance brain levels of dopamine, the neurotransmitter deficient…  
  • Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs…  
  • Galantamine, a cholinesterase inhibitor, delays Alzheimer’s patients’ need for full-time care, with overall cost savings estimated between $323 and $4,256 per patient.